静脉穿刺市场：按设备类型、应用和最终用户划分 - 2026-2032年全球市场预测

预计到 2025 年，静脉穿刺市场价值将达到 13.7 亿美元，到 2026 年将成长到 14.6 亿美元，到 2032 年将达到 23 亿美元，复合年增长率为 7.60%。

主要市场统计数据
基准年 2025	13.7亿美元
预计年份：2026年	14.6亿美元
预测年份 2032	23亿美元
复合年增长率 (%)	7.60%

本文全面概述了静脉穿刺手术，重点介绍了其临床意义、手术的复杂性以及医疗保健服务中不断变化的营运重点。

静脉穿刺仍然是所有医疗机构中用于诊断、治疗监测和输血服务的基本临床操作。儘管其技术操作简单，但实际操作却十分复杂。正确的技术、设备的选择以及对安全通讯协定的遵守共同决定了检体的完整性、病患体验和职业安全。过去十年，临床工作的重点已从单纯地提高操作成功率转向在不同的医疗环境中整合设备安全、病患舒适度和工作流程效率。

诊断的去中心化、以安全为中心的医疗设备的创新以及采购系统的演变，正在重新定义整个医疗保健环境中的静脉穿刺实践。

受临床、技术和製度等多方面因素的影响，血液采集领域正在经历变革性的变化。在临床方面，即时检测和分散式医疗模式的推广，使得血液施行地点从医院检查室扩展到门诊诊所、居家医疗机构和急诊检测场所。这种医疗服务的扩散，增加了对既要操作简单又要保证检体完整性和生物安全防护的设备的需求。

近期关税和贸易政策变化对静脉穿刺器械采购、采购韧性和供应链风险缓解策略的累积影响。

近期政策週期中实施的贸易政策调整和关税措施对血液采集设备生态系统产生了累积影响，改变了采购模式和成本结构。进口医疗组件和原材料的关税相关价格上涨，导致医院和经销商对采购流程进行更严格的审查，促使供应商多元化，并对总拥有成本（TCO）进行更严格的评估。为此，许多相关人员优先考虑近岸外包、替代采购管道以及加强供应商合同，以降低交货波动的影响。

基于实际细分的洞察，将应用需求、设备设计差异和各种最终用户操作需求连结起来，以支援采购和产品策略的发展。

市场细分提供了一种系统地将临床需求转化为采购和产品开发优先事项的方法。根据应用领域，捐血、临床诊断和科研领域的市场功能需求各不相同。特别是临床诊断，它包含临床化学、凝血、血液学、免疫学和微生物学等子领域，每个领域对检体量、抗凝血剂相容性和周转时间都有独特的要求。这些应用层级的差异导致了仪器选择的多样性，从核心检查室的高通量真空系统到用于紧急采血的紧凑型翼式采血器，甚至包括用于科研环境中处理小检体或高灵敏度分析物的专用采血设备。

影响美洲、欧洲、中东和非洲以及亚太地区医疗器材采用和采购模式的区域因素。

区域趋势正以不同的方式影响临床环境、监管要求和供应链结构。在美洲，医疗保健系统呈现出多种多样的采购模式，从集中式医院网路到社区诊所，这推动了对高通量吸痰系统和用于分散式检查的携带式的需求。强调职业安全和感染控制的法律规范正在促进安全设计设备的采用和全面用户培训计划的实施。

製造商、创新专家和通路合作伙伴如何协调产品演进、临床检验和分销策略，以满足不断变化的血液采集需求。

产业相关人员正透过优先考虑安全性、互通性和供应链灵活性来满足临床和营运需求。成熟的製造商持续投资于抽吸系统和安全注射器的分阶段改进，强调与自动化分析仪的兼容性以及易于整合到检查室工作流程中。同时，专业公司和Start-Ups则专注于差异化功能，例如符合人体工学的设计、增强的针头安全机制以及可降低检体吸附和溶血风险的材料。

为医疗设备製造商、医疗保健提供者和采购经理提供可操作的策略行动，以提高安全性、增强供应韧性并加速静脉穿刺解决方案的临床部署。

产业领导者应采取多管齐下的策略，以确保临床意义和供应稳定性。首先，应优先考虑设备安全性和以使用者为中心的设计，投资严格的人体工学测试和以临床医生主导的改进措施。这将有助于减少工伤事故并提高检体品质。其次，应加强供应商多元化和短期库存规划，以降低关税波动和运输风险带来的影响。合约柔软性和双源采购安排可以减少外部政策衝击的影响。

我们透过高度透明的混合调查方法确保了严谨的见解，该方法结合了与临床医生的直接互动、对工作流程的观察分析以及有关法规和贸易的二手资讯。

本研究采用一手调查和二手调查相结合的方法，以确保研究结果的全面性和检验。一手调查包括对临床实验室经理、采血技师、采购经理和医疗设备工程师进行结构化访谈和专题讨论，以了解不同环境下医疗器材应用的实际情况、挑战和驱动因素。来自临床工作流程评估的观察数据提供了影响器械选择的时间和操作因素、储存限制以及临床环境中的交互作用等背景资讯。

简要总结了结论，重点阐述了以安全为中心的创新、营运一致性和供应链韧性如何结合起来改善静脉穿刺结果。

血液采样仍然是一项影响深远的临床活动，其技术的逐步改进能够显着提高诊断准确性、改善患者体验并保障医护人员安全。无论设备类型或医疗环境如何，相关人员都已将安全至上的设计理念、与自动化临床实验室系统的互通性以及注重韧性的筹资策略视为优先事项。贸易政策趋势和供应链压力凸显了灵活采购以及製造商与医疗采购方之间更紧密合作的必要性。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：静脉穿刺术市场：依器械类型划分

• 毛细管
• 吸力系统
  • 玻璃
  • 塑胶
• 注射器
  • 预填充式注射器
  • 标准注射器
• 带翅膀

第九章：静脉穿刺市场：依应用领域划分

• 捐血
• 临床诊断
  • 临床化学
  • 凝血
  • 血液学
  • 免疫学
  • 微生物学
• 研究

第十章：静脉穿刺市场：依最终用户划分

• 门诊治疗
• 诊断检查室
• 居家医疗
• 医院检查室
  • 核心检查室
  • 护理点
  • 急诊检查室

第十一章：静脉穿刺市场：按地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十二章：静脉穿刺市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十三章：静脉穿刺市场：依国家划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十四章：美国静脉穿刺手术市场

第十五章：中国静脉穿刺市场

第十六章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Greiner Bio-One International GmbH
• Medline Industries, Inc.
• Merck KGaA
• Nipro Corporation
• PH Healthcare Pvt. Ltd.
• Parker Hannifin Corporation
• Sarstedt AG & Co. KG
• Sharn Inc.
• Smiths Medical, Inc.
• Terumo Corporation
• Thermo Fisher Scientific Inc.
• TransLite LLC
• Venoscope, LLC
• Vygon SA

The Venipuncture Procedure Market was valued at USD 1.37 billion in 2025 and is projected to grow to USD 1.46 billion in 2026, with a CAGR of 7.60%, reaching USD 2.30 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.37 billion
Estimated Year [2026]	USD 1.46 billion
Forecast Year [2032]	USD 2.30 billion
CAGR (%)	7.60%

A comprehensive introductory overview of venipuncture procedures highlighting clinical importance, procedural complexity, and evolving operational priorities in healthcare delivery

Venipuncture remains a foundational clinical procedure underpinning diagnostics, therapeutic monitoring, and transfusion services across healthcare settings. Its technical simplicity belies operational complexity: proper technique, device selection, and adherence to safety protocols collectively determine specimen integrity, patient experience, and occupational safety. Over the past decade, clinical priorities have shifted from exclusively optimizing procedural success rates to integrating device safety, patient comfort, and workflow efficiency across diverse points of care.

Consequently, stakeholders including clinicians, laboratory managers, procurement teams, and device manufacturers have elevated their focus on harmonizing training, standard operating procedures, and procurement criteria to reduce pre-analytical variability. This introductory overview sets the stage for a deeper examination of how technological innovation, regulatory scrutiny, and changing care delivery models are reshaping venipuncture practice. In the sections that follow, we trace these transformations and outline practical implications for clinical operations and supply-chain leadership.

How decentralization of diagnostics, safety-driven device innovation, and procurement evolution are collectively redefining venipuncture practice across care environments

The landscape surrounding venipuncture is undergoing transformative shifts driven by converging clinical, technological, and systemic forces. At the clinical front, the expansion of point-of-care testing and decentralized care models has extended venipuncture beyond hospital laboratories into ambulatory clinics, home healthcare settings, and stat testing environments. This diffusion of care has intensified demand for devices that balance ease of use with robust specimen integrity and biohazard containment.

Technological innovation has been another vector of change. Advances in evacuated systems, safety-engineered syringes, and winged sets have reduced needlestick incidents and improved sample consistency, while the move from glass to plastic components in some devices has altered handling and storage protocols. Regulatory emphasis on occupational safety standards and pre-analytical quality control is prompting manufacturers to redesign devices and provide enhanced user education. Meanwhile, procurement strategies are evolving as healthcare organizations prioritize lifecycle costs, single-use safety, and compatibility with automated processing equipment. Taken together, these shifts are redefining how venipuncture is taught, executed, and procured across care settings.

Observed cumulative effects of recent tariff and trade policy shifts on venipuncture device sourcing, procurement resilience, and supply-chain risk mitigation strategies

Trade policy adjustments and tariff measures implemented in recent policy cycles have exerted a cumulative influence on the venipuncture device ecosystem, altering sourcing patterns and cost structures. Tariff-related increases on imported medical components and raw materials have contributed to heightened procurement scrutiny among hospitals and distributors, prompting closer assessment of supplier diversification and total cost of ownership. In response, many stakeholders have prioritized nearshoring, alternative sourcing, and strengthened supplier contracts to mitigate delivery volatility.

These policy-induced pressures have also accelerated supply-chain risk management practices. Procurement teams have increased safety-stock thresholds for critical consumables and have sought contractual protections against freight and tariff variability. At the same time, clinicians and laboratory managers have had to balance cost containment with uncompromising requirements for specimen quality and staff safety. As a result, the sector has seen an uptick in collaboration between device manufacturers and institutional buyers to identify design or material substitutions that preserve clinical performance while easing tariff exposure, thereby maintaining continuity of care despite external trade headwinds.

Actionable segmentation-driven insights linking application demands, device design distinctions, and diverse end-user operational needs to inform procurement and product strategy

Segmentation provides a structured way to translate clinical needs into procurement and product development priorities. Based on application, the market's functional demands differ across blood donation, clinical diagnostics, and research. Clinical diagnostics in particular encompasses subdomains such as clinical chemistry, coagulation, hematology, immunology, and microbiology, each imposing distinct requirements for specimen volume, anticoagulant compatibility, and turnaround time. These application-level distinctions drive variations in device preference, from high-throughput evacuated systems in core laboratories to compact winged sets for stat draws and specialized collection devices used in research settings with low-volume or sensitive analytes.

Based on device type, product design and material choices meaningfully affect usability and waste management. Capillary tubes remain critical for low-volume or pediatric sampling, while evacuated systems, available in glass and plastic, serve as the backbone for routine diagnostic workflows due to their standardization and compatibility with automation. Syringes-offered as prefilled or standard configurations-address niche clinical needs where precise dosing or aspiration control is required. Winged sets continue to be favored for difficult venous access. Each device family presents specific training, storage, and sterilization considerations that influence procurement and clinical adoption.

Based on end user, the operational context dictates purchasing criteria and device selection. Ambulatory care centers and home healthcare environments prioritize compact, user-friendly devices and simplified waste handling, whereas diagnostic laboratories focus on throughput, compatibility with analyzers, and pre-analytical quality. Hospital laboratories, which include core laboratories, point-of-care testing sites, and stat laboratories, require a portfolio approach to address diverse clinical workflows and emergency demands. These segmentation lenses reveal where product innovation and service offerings will have the greatest practical impact across the care continuum.

Regional forces shaping device adoption and procurement patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific healthcare markets

Regional dynamics shape clinical practice, regulatory requirements, and supply-chain configuration in distinct ways. In the Americas, healthcare systems exhibit a wide range of procurement models from centralized hospital networks to community-based clinics, which shapes demand for both high-throughput evacuated systems and portable devices for decentralized testing. Regulatory frameworks emphasizing occupational safety and infection control have driven adoption of safety-engineered devices and comprehensive user training programs.

In Europe, Middle East & Africa, heterogeneous regulatory environments and varying healthcare infrastructure levels create opportunities for both advanced device adoption in tertiary care centers and cost-sensitive product selection in resource-constrained settings. Regional procurement collaborations and tendering mechanisms can influence device standardization, while local manufacturing capacity in certain countries supports resilience against international supply disruptions.

In Asia-Pacific, rapid expansion of diagnostic services, a growing emphasis on home and community care, and substantial investments in laboratory automation are shifting procurement toward scalable device families. The region's manufacturing base also plays a pivotal role in global supply chains, enabling quicker responses to regional demand surges but also introducing sensitivities to export controls and raw material availability. Across regions, clinical training, reimbursement policies, and institutional procurement practices remain key determinants of device uptake and lifecycle management.

How manufacturers, specialist innovators, and channel partners are aligning product evolution, clinical validation, and distribution strategies to meet shifting venipuncture demands

Industry players are responding to clinical and operational demands by prioritizing safety, interoperability, and supply-chain agility. Established manufacturers continue to invest in incremental improvements to evacuated systems and safety syringes, emphasizing compatibility with automated analyzers and ease of integration into laboratory workflows. At the same time, specialist firms and startups are focusing on differentiated features such as ergonomic designs, enhanced needle-safety mechanisms, and materials that reduce sample adsorption or hemolysis risk.

Strategic partnerships between device developers and clinical networks have increased to support real-world evaluation and iterative product enhancement. Contract manufacturing and third-party sterilization services have grown in importance as manufacturers seek to scale without heavy capital outlay. Distribution channels are evolving too, with service offerings that bundle training, waste disposal solutions, and data capture tools to support quality assurance. Competitive dynamics favor organizations that can demonstrate both clinical efficacy and operational savings through reduced needlestick injuries, streamlined workflows, and lower overall handling risk.

Practical strategic actions for device makers, healthcare providers, and procurement leaders to strengthen safety, supply resilience, and clinical uptake of venipuncture solutions

Industry leaders should adopt a multi-pronged approach to secure clinical relevance and supply resilience. First, prioritize device safety and user-centered design by investing in rigorous human factors testing and clinician-driven iterations; this will reduce occupational injuries and improve specimen quality. Second, strengthen supplier diversification and near-term inventory planning to mitigate tariff sensitivity and shipping volatility; contractual flexibility and dual-sourcing arrangements will reduce exposure to external policy shocks.

Third, enhance clinical and procurement alignment by creating cross-functional evaluation committees that weigh total cost of ownership alongside pre-analytical quality metrics. Fourth, accelerate partnerships with clinical sites for real-world evidence generation to demonstrate device performance across diverse care settings, emphasizing point-of-care and home healthcare scenarios. Fifth, invest in training and digital support tools that standardize technique and reduce variability across end users. Finally, consider modular product portfolios that allow rapid substitution of materials or components to respond to regulatory changes or supply constraints without compromising clinical performance. These actions, taken together, will enable organizations to maintain continuity of care, preserve specimen integrity, and capture emerging opportunities in decentralized diagnostics.

A transparent mixed-methods research methodology combining primary clinician engagement, observational workflow analysis, and secondary regulatory and trade sources to ensure rigorous insights

The research approach combined primary and secondary methods to ensure comprehensive, validated insights. Primary research included structured interviews and targeted discussions with clinical laboratory directors, phlebotomists, procurement managers, and device engineers to capture operational realities, pain points, and adoption drivers across settings. Observational inputs from clinical workflow assessments provided context on time-motion factors, storage constraints, and point-of-care interactions that influence device selection.

Secondary research leveraged peer-reviewed literature, clinical guidelines, and regulatory standards to ground findings in current best practices and safety requirements. Trade publications and public customs and tariff disclosures were analyzed to understand supply-chain disruptions and policy impacts. Data triangulation techniques were applied to reconcile qualitative practitioner feedback with documented standards and trade information. The methodology acknowledges limitations: respondent perspectives vary by geography and institution type, and material substitution effects depend on local regulatory acceptance. Nonetheless, the combined methods yield robust directional insights suitable for informing procurement, product development, and clinical training programs.

A concise concluding synthesis highlighting how safety-focused innovation, operational alignment, and supply resilience converge to improve venipuncture outcomes

Venipuncture remains a high-impact clinical activity where incremental improvements yield outsized benefits for diagnostic accuracy, patient experience, and staff safety. Across device types and care settings, stakeholders are converging on priorities that include safety-engineered designs, interoperability with laboratory automation, and procurement strategies that emphasize resilience. Trade policy developments and supply-chain pressures have heightened the need for flexible sourcing and closer collaboration between manufacturers and institutional buyers.

Looking ahead, organizations that align product innovation with real-world clinical workflows and that proactively manage supply-chain and regulatory risk will be best positioned to deliver value. Translating these conclusions into practical initiatives-such as targeted training programs, dual-sourcing arrangements, and clinical validation partnerships-will accelerate adoption of safer, more reliable venipuncture practices that serve both patient and system-level objectives.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Venipuncture Procedure Market, by Device Type

• 8.1. Capillary Tubes
• 8.2. Evacuated Systems
  • 8.2.1. Glass
  • 8.2.2. Plastic
• 8.3. Syringes
  • 8.3.1. Prefilled Syringes
  • 8.3.2. Standard Syringes
• 8.4. Winged Sets

9. Venipuncture Procedure Market, by Application

• 9.1. Blood Donation
• 9.2. Clinical Diagnostics
  • 9.2.1. Clinical Chemistry
  • 9.2.2. Coagulation
  • 9.2.3. Hematology
  • 9.2.4. Immunology
  • 9.2.5. Microbiology
• 9.3. Research

10. Venipuncture Procedure Market, by End User

• 10.1. Ambulatory Care
• 10.2. Diagnostic Laboratories
• 10.3. Home Healthcare
• 10.4. Hospital Laboratories
  • 10.4.1. Core Laboratories
  • 10.4.2. Point Of Care
  • 10.4.3. Stat Laboratories

11. Venipuncture Procedure Market, by Region

• 11.1. Americas
  • 11.1.1. North America
  • 11.1.2. Latin America
• 11.2. Europe, Middle East & Africa
  • 11.2.1. Europe
  • 11.2.2. Middle East
  • 11.2.3. Africa
• 11.3. Asia-Pacific

12. Venipuncture Procedure Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Venipuncture Procedure Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. United States Venipuncture Procedure Market

15. China Venipuncture Procedure Market

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025
• 16.5. B. Braun Melsungen AG
• 16.6. Becton, Dickinson and Company
• 16.7. Cardinal Health, Inc.
• 16.8. Greiner Bio-One International GmbH
• 16.9. Medline Industries, Inc.
• 16.10. Merck KGaA
• 16.11. Nipro Corporation
• 16.12. P. H. Healthcare Pvt. Ltd.
• 16.13. Parker Hannifin Corporation
• 16.14. Sarstedt AG & Co. KG
• 16.15. Sharn Inc.
• 16.16. Smiths Medical, Inc.
• 16.17. Terumo Corporation
• 16.18. Thermo Fisher Scientific Inc.
• 16.19. TransLite LLC
• 16.20. Venoscope, LLC
• 16.21. Vygon S.A.

LIST OF FIGURES

• FIGURE 1. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL VENIPUNCTURE PROCEDURE MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL VENIPUNCTURE PROCEDURE MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 11. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CAPILLARY TUBES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CAPILLARY TUBES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CAPILLARY TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STANDARD SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STANDARD SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY WINGED SETS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY WINGED SETS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY WINGED SETS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BLOOD DONATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BLOOD DONATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY BLOOD DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CORE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CORE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY CORE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STAT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STAT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY STAT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 79. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 80. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 81. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 82. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 83. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 84. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 85. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 86. AMERICAS VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 87. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 88. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 89. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 90. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 91. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 92. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 93. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 94. NORTH AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 95. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 96. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 97. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 98. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 99. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 100. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 101. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 102. LATIN AMERICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 111. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 112. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 113. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 114. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 115. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 116. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 117. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. EUROPE VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 119. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 120. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 121. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 122. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 123. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 124. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 125. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 126. MIDDLE EAST VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 127. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 128. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 129. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 130. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 131. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 132. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 133. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 134. AFRICA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 135. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 137. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 138. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 139. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 140. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 141. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 142. ASIA-PACIFIC VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 143. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 144. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 145. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 146. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 147. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 148. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 149. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 150. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 151. ASEAN VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 152. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 153. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 154. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 155. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 156. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 157. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 158. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 159. GCC VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 160. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 161. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 162. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 163. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 164. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 165. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 166. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 167. EUROPEAN UNION VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 168. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 169. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 170. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 171. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 172. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 173. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 174. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 175. BRICS VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 176. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 177. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 178. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 179. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 180. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 181. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 182. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. G7 VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 184. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 185. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 186. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 187. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 188. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 189. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 190. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 191. NATO VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 192. GLOBAL VENIPUNCTURE PROCEDURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 193. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 194. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 195. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 196. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 197. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 198. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 199. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 200. UNITED STATES VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)
• TABLE 201. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 202. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
• TABLE 203. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY EVACUATED SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 204. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
• TABLE 205. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 206. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
• TABLE 207. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 208. CHINA VENIPUNCTURE PROCEDURE MARKET SIZE, BY HOSPITAL LABORATORIES, 2018-2032 (USD MILLION)